Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia

Journal of Clinical Oncology

Volumn 12, Issue 2, 1994, Pages 262-267

  Archimbaud, Eric ^a   Thomas, Xavier ^b   Michallet, Mauricette ^b   Jaubert, Jerome ^b   Troncy, Jacques ^b   Guyotat, Denis ^b   Fiere, Denis ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; CYTARABINE; DAUNORUBICIN; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; FEMALE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZATION; RECURRENCE RISK;

EID: 0027980174     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1994.12.2.262     Document Type: Article

References (22)

1. Champlin R, Gale RP: Acute myelogenous leukemia: Recent advances in therapy. Blood 69:1551-1562, 1987
2. Geller R: Post remission therapy of acute myelocytic leukemia in adults: Curability breeds controversy. Leukemia 6:915-925, 1992
3. Report from the Working Party on Leukaemia, European Group for Bone Marrow Transplantation: Allogeneic bone marrow transplantation for leukaemia in Europe. Lancet 1:1379-1382, 1988
4. Gale RP, Horowitz MM, Bortin MM: IBMTR analysis of bone marrow transplants in acute leukemia. Bone Marrow Transplant 3:83-84, 1989 (suppl 3)
5. Champlin RE, Ho WG, Gale RP, et al: Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Intern Med 102:285-291, 1985
6. Appelbaum FR, Fisher LD, Thomas ED: Chemotherapy versus marrow transplantation for adults with acute nonlymphocytic leukemia: A five-year follow-up. Blood 72:179-184, 1988
7. Zander AR, Keating M, Dicke K, et al: A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission. J Clin Oncol 6:1548-1557, 1988
8. Conde E, Iriondo A, Rayon C, et al: Allogeneic bone marrow transplantation versus intensification chemotherapy for acute myelogenous leukaemia in first remission: A prospective controlled trial. Br J Haematol 68:219-226, 1988
9. Reiffers J, Gaspard MH, Maraninchi D, et al: Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: A prospective controlled trial. Br J Haematol 72:57-63, 1989
10. Dahl VG, Kalwinsky DK, Mirro J, et al: Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 8:295-303, 1990
11. Ferrant A, Doyen C, Delannoy A, et al: Allogeneic or autologous bone marrow transplantation for acute nonlymphocytic leukemia in first remission. Bone Marrow Transplant 7:303-309, 1991
12. Willemze R, Fibbe WE, Kluin-Nelemans JC, et al: Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia. Ann Hematol 62:59-63, 1991
13. Schiller GJ, Nimer SD, Territo MC, et al: Bone marrow transplantation versus high-dose cytarabine-based combination chemotherapy for acute myelogenous leukemia in first remission. J Clin Oncol 10:41-46, 1992
14. Amadori S, Testi AM, Arico M, et al: Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol 11:1046-1054, 1993
15. Ljungman P, de Witte T, Verdonck L, et al: Bone marrow transplantation for acute myeloblastic leukemia: An EBMT Leukemia Working Party prospective analysis from HLA-typing. Br J Haematol 84:61-66, 1993
16. Bennett JM, Catovsky D, Daniel MT, et al: Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group. Ann Intern Med 103:626-629, 1985
17. Ellison RR, Holland JF, Weil M, et al: Arabinosyl cytosine: A useful agent in the treatment of acute leukemia in adults. Blood 32:507-523, 1968
18. Archimbaud E, Leblond V, Michallet M, et al: Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for resistant or relapsing acute myelogenous leukemia. Blood 77:1894-1900, 1991
19. Fenaux P, Castaigne S, Dombret H, et al: All transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases. Blood 80:2176-2181, 1992
20. Blaise D, Maraninchi D, Archimbaud E, et al: Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: A randomized trial of a busulfan-cytoxan versus cytoxantotal body irradiation as preparative regimen. A report from the GEGMO. Blood 79:2578-2582, 1992
21. Thomas X, Archimbaud E, Treille-Ritouet D, et al: Prognostic factors in acute promyelocytic leukemia: A retrospective study of 67 cases. Leuk Lymphoma 4:249-256, 1991
22. Fenaux P: Management of acute promyelocytic leukemia. Eur J Haematol 50:65-73, 1993